cardiovascular system
• changes in mitral-valve shape are seen at E15.5-E17.5, but not at E11.5-E13.5, with changes in valve length and width at E17.
|
• myxomatous degeneration with increased proteoglycan accumulation in both mitral leaflets
|
• prominent posterior leaflet thickening with increases in valve volume in adults
|
• mitral valve prolapse with pronounced involvement of the posterior leaflet, which is elongated and shifts the leaflet coaptation anteriorly
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
mitral valve prolapse | DOID:988 |
OMIM:157700 OMIM:607829 OMIM:610840 |
J:225789 |